Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Talbot

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|April 1, 1986
Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adultsE L Larson, K J McGinley, J J Leyden, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 16, 2000
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus punctureN Garrison, S Spector, D Buffington, et al.
The American Journal of Medicine|June 1, 1984
Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS M Albelda, G H Talbot, S L Gerson, et al.
Clinical Therapeutics|August 27, 1999
Pharmacokinetics of sparfloxacin in patients with renal impairmentM B Dorr, R D Johnson, B Jensen, et al.
Clinical Therapeutics|July 9, 1999
Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval)J Morganroth, G H Talbot, M B Dorr, et al.
Clinical Therapeutics|August 10, 1999
Effects of food on the pharmacokinetics of sparfloxacinR D Johnson, M B Dorr, T L Hunt, et al.
The American Review of Respiratory Disease|January 1, 1985
Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemiaS M Albelda, G H Talbot, S L Gerson, et al.
Obstetrics and Gynecology|March 1, 1986
Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infectionsG Herman, A W Cohen, G H Talbot, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study GroupR C Moellering, P K Linden, J Reinhardt, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|April 1, 1986
Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adultsE L Larson, K J McGinley, J J Leyden, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 16, 2000
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus punctureN Garrison, S Spector, D Buffington, et al.
The American Journal of Medicine|June 1, 1984
Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemiaS M Albelda, G H Talbot, S L Gerson, et al.
Clinical Therapeutics|August 27, 1999
Pharmacokinetics of sparfloxacin in patients with renal impairmentM B Dorr, R D Johnson, B Jensen, et al.
Clinical Therapeutics|July 9, 1999
Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval)J Morganroth, G H Talbot, M B Dorr, et al.
Clinical Therapeutics|August 10, 1999
Effects of food on the pharmacokinetics of sparfloxacinR D Johnson, M B Dorr, T L Hunt, et al.
The American Review of Respiratory Disease|January 1, 1985
Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemiaS M Albelda, G H Talbot, S L Gerson, et al.
Obstetrics and Gynecology|March 1, 1986
Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infectionsG Herman, A W Cohen, G H Talbot, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study GroupR C Moellering, P K Linden, J Reinhardt, et al.
Pageof 8